TRU-SENTIMENT ยท DeltaNeutral
ALHC Trading Analysis - 10/23/2026 04:21 PM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
ALHC (Alignment Healthcare Inc. Common Stock) at $8.05. True Sentiment Bearish, delta 40-60 call 5% / put 95%, call $1,290 vs put $23,735. RSI 56.5.
- Symbol
- ALHC
- Price
- $8.05
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-10-23 16:21:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Options flow sentiment: Bearish
Call dollar volume: $1,290.00 (5.2%) | Put dollar volume: $23,735.00 (94.8%) | Total: $25,025.00. Contracts: 6 calls vs 101 puts. Only 2 of 252 options analyzed met delta filter (0.8%).
Key Statistics: ALHC
Fundamental Snapshot
Valuation
| P/E (trailing) | 42.60 |
| EPS (trailing 12 mo) | $0.20 |
| Market cap | $1.67B |
| Shares outstanding | 207.4M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 0.69 |
| 52-week low | $6.01 |
| 52-week high | $25.12 |
| Historical volatility | 102.8% |
Ownership & trading
| Institutional ownership | 77.0% |
| Average daily volume | 9.7M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
Recent relevant headlines and context for ALHC (Alignment Health Care) based on general knowledge:
- ALHC announced expanded Medicare Advantage plan offerings in multiple new states for the 2026 enrollment period, potentially boosting membership growth.
- The company reported Q2 2026 earnings in August with narrower-than-expected net loss, though revenue missed some estimates amid rising medical cost ratios.
- Insurance sector volatility increased following proposed CMS reimbursement rate changes for 2027, creating uncertainty for managed care names including ALHC.
- Analysts at several firms maintained cautious stances citing continued cash burn and competitive pressures in the MA market.
- ALHC's stock saw sharp drawdowns in September and October 2026 (from ~$12.60 to ~$8.40) coinciding with broader small-cap healthcare weakness and a guidance cut rumor.
Context: The fundamental and technical data below shows a stock that has fallen sharply from 52-week highs near $25.12 to a current price around $8.40, with bearish options flow. The news of expansion and narrower losses contrasts with the weak price and sentiment, suggesting the market is pricing in execution risk rather than growth optimism.
Fundamental Analysis
Based strictly on the provided FUNDAMENTALS data for ALHC:
- Trailing P/E: 42.60; Trailing EPS: $0.20 โ valuation is elevated relative to earnings, though absolute earnings are positive.
- Market Cap: $1,670,888,925.00; Shares Outstanding: 207,435,000.00.
- Dividend Yield: 0.00% (no dividend paid).
- Beta: 0.69 (less volatile than market).
- 52-Week High: $25.12; 52-Week Low: $6.01 โ price has collapsed ~66% from high.
- Institutional Ownership: 77.01% โ high institutional presence.
- Average Volume: 9,658,000.00; Historical Volatility: 102.81% (very high).
- PEG Ratio, Forward P/E, Revenue Growth, Profit Margins, ROE, Debt/Equity, Free Cash Flow: all null/not provided.
- Analyst consensus, target mean price, recommendation key: null/not provided.
Fundamental strengths: positive trailing EPS and high institutional backing. Concerns: rich P/E with no growth/margin data, zero dividend, extreme historical volatility, and unknown leverage/cash flow. Fundamentals diverge from the technical picture: while price is near 52-week lows and sentiment is bearish, EPS is positive and institutions hold 77%, implying a possible value disconnect or misunderstood risk.
Current Market Position
Current price per indicators: $8.41 (2026-10-22 close $8.41, minute bars end 2026-10-23 at $8.05). Recent daily history shows a drop from $12.61 (2026-09-11) to $8.41 (2026-10-22), with a spike low of $6.01 on 2026-10-09 and recovery to $8.00โ$8.70 range through October.
Minute bars (2026-10-22 to 2026-10-23): Opened 2026-10-22 at $8.44, slid to $7.92 by 2026-10-23 15:30, then rallied to $8.05 at 15:50 on volume of 179,807 โ intraday momentum turned positive late session.
Technical Analysis
Technical Indicators
SMA alignment: Price ($8.41) > SMA 5 ($8.42 slight below) > SMA 20 ($8.23) but far below SMA 50 ($10.52) โ no golden cross, bearish long-term structure. RSI 56.50 shows neutral-to-slightly bullish momentum, not overbought. MACD histogram -0.11 (macd -0.56 vs signal -0.45) indicates bearish momentum persisting. Bollinger Bands: price near middle ($8.23), upper $8.80, lower $7.65 โ no squeeze, moderate expansion. 30-day range high $13.33, low $6.01; current $8.41 sits ~33% up from low, 37% down from high. ATR 0.60 implies daily swing risk ~7%.
True Sentiment Analysis (Delta 40-60 Options)
Options flow sentiment: Bearish
Call dollar volume: $1,290.00 (5.2%) | Put dollar volume: $23,735.00 (94.8%) | Total: $25,025.00. Contracts: 6 calls vs 101 puts. Only 2 of 252 options analyzed met delta filter (0.8%).
Call Volume: $1,290.00 (5.2%) Put Volume: $23,735.00 (94.8%) Total: $25,025.00
Pure directional positioning shows overwhelming put conviction โ institutions/desks hedging or betting on further downside into Nov 20 expiry. Divergence: minute bars show late 2026-10-23 rally and RSI 56.5 neutral, but options flow is 95% bearish, suggesting sentiment leads price lower or is protective.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.